For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Diabetes With HH: Testosterone | active drug diabetes hypogonadal arm testosterone: intramuscular every 2 weeks | None | None | 0 | 22 | 0 | 22 | View |
| Diabetes With HH: Placebo | placebo diabetes hypogonadal arm placebo: saline intramuscular every 2 weeks | None | None | 0 | 22 | 0 | 22 | View |
| Obese With HH: Testosterone | active drug obese hypogonadal arm testosterone: intramuscular every 2 weeks | None | None | 0 | 12 | 0 | 12 | View |
| Obese With HH: Placebo | placebo obese hypogonadal arm placebo: saline intramuscular every 2 weeks | None | None | 0 | 10 | 0 | 10 | View |
| Eugonadal Diabetes | diabetic men with normal testosterone | None | None | 0 | 50 | 0 | 50 | View |
| Eugonadal Obese | obese non-diabetic men with normal testosterone | None | None | 0 | 21 | 0 | 21 | View |